Dr. Bernd Seilheimer
Bernd Seilheimer is a Neuroscientist by training. He postgraduated at the University of Heidelberg, Germany and Harvard Medical School, Boston, USA. He looks back at a long career in pharmaceutical industry (Hoffmann-La Roche, Schering AG, Bayer Schering Pharma) where he held several different management positions. From 2002-2010 he was a board member of the European Neuroscience Institute (ENI), Göttingen and from 2006 on a member of the Council of Scientific and Business Advisors of the Johnnie B. Byrd Institute, Florida, USA. He joined Biologische Heilmittel Heel GmbH in 2009.
In his role as Head of Systems Research and Development he is responsible for the broadening of the scientific knowledge base related to the company’s product portfolio. He makes sure that state-of-the-art technology platforms are applied and cooperations with centers of excellence are established.